KANZHUN LTD - ADR (BZ) Fundamental Analysis & Valuation

NASDAQ:BZ • US48553T1060

15.54 USD
-0.33 (-2.08%)
At close: Mar 5, 2026
15.5 USD
-0.04 (-0.26%)
After Hours: 3/5/2026, 8:00:02 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Forecast Earnings Financials Ownership News

This BZ fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

Fundamental Rating

6

We assign a fundamental rating of 6 out of 10 to BZ. BZ was compared to 88 industry peers in the Professional Services industry. BZ is in great health and has no worries on liquidiy or solvency at all, but the profibility rating is only average. BZ scores decently on growth, while it is valued quite cheap. This could make an interesting combination. With these ratings, BZ could be worth investigating further for value investing!.


Dividend Valuation Growth Profitability Health

6

1. BZ Profitability Analysis

1.1 Basic Checks

  • BZ had positive earnings in the past year.
  • In the past year BZ had a positive cash flow from operations.
  • In multiple years BZ reported negative net income over the last 5 years.
  • Each year in the past 5 years BZ had a positive operating cash flow.
BZ Yearly Net Income VS EBIT VS OCF VS FCFBZ Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 2024 0 1B -1B 2B 3B

1.2 Ratios

  • BZ has a better Return On Assets (10.31%) than 81.82% of its industry peers.
  • Looking at the Return On Equity, with a value of 12.92%, BZ is in the better half of the industry, outperforming 62.50% of the companies in the same industry.
  • BZ's Return On Invested Capital of 9.77% is fine compared to the rest of the industry. BZ outperforms 67.05% of its industry peers.
Industry RankSector Rank
ROA 10.31%
ROE 12.92%
ROIC 9.77%
ROA(3y)5.02%
ROA(5y)-3.62%
ROE(3y)6.59%
ROE(5y)-5.82%
ROIC(3y)N/A
ROIC(5y)N/A
BZ Yearly ROA, ROE, ROICBZ Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 2024 0 -20 -40 -60 -80

1.3 Margins

  • BZ has a Profit Margin of 31.09%. This is amongst the best in the industry. BZ outperforms 97.73% of its industry peers.
  • The Operating Margin of BZ (26.94%) is better than 94.32% of its industry peers.
  • BZ's Gross Margin of 84.53% is amongst the best of the industry. BZ outperforms 95.45% of its industry peers.
  • BZ's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 26.94%
PM (TTM) 31.09%
GM 84.53%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.49%
GM growth 5Y-0.72%
BZ Yearly Profit, Operating, Gross MarginsBZ Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 2024 0 50 -50

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

7

2. BZ Health Analysis

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), BZ is creating some value.
  • BZ has less shares outstanding than it did 1 year ago.
  • The number of shares outstanding for BZ has been increased compared to 5 years ago.
  • BZ has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
BZ Yearly Shares OutstandingBZ Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M
BZ Yearly Total Debt VS Total AssetsBZ Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 5B 10B 15B

2.2 Solvency

  • There is no outstanding debt for BZ. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z N/A
ROIC/WACC1.3
WACC7.54%
BZ Yearly LT Debt VS Equity VS FCFBZ Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 2024 0 5B 10B

2.3 Liquidity

  • A Current Ratio of 4.18 indicates that BZ has no problem at all paying its short term obligations.
  • BZ has a better Current ratio (4.18) than 93.18% of its industry peers.
  • BZ has a Quick Ratio of 4.18. This indicates that BZ is financially healthy and has no problem in meeting its short term obligations.
  • The Quick ratio of BZ (4.18) is better than 93.18% of its industry peers.
Industry RankSector Rank
Current Ratio 4.18
Quick Ratio 4.18
BZ Yearly Current Assets VS Current LiabilitesBZ Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 5B 10B 15B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

6

3. BZ Growth Analysis

3.1 Past

  • BZ shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 30.62%, which is quite impressive.
  • The Revenue has grown by 12.66% in the past year. This is quite good.
  • Measured over the past years, BZ shows a very strong growth in Revenue. The Revenue has been growing by 49.09% on average per year.
EPS 1Y (TTM)30.62%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%31.71%
Revenue 1Y (TTM)12.66%
Revenue growth 3Y19.98%
Revenue growth 5Y49.09%
Sales Q2Q%13.17%

3.2 Future

  • Based on estimates for the next years, BZ will show a decrease in Earnings Per Share. The EPS will decrease by -2.51% on average per year.
  • Based on estimates for the next years, BZ will show a quite strong growth in Revenue. The Revenue will grow by 11.40% on average per year.
EPS Next Y34.19%
EPS Next 2Y23.01%
EPS Next 3Y21.02%
EPS Next 5Y-2.51%
Revenue Next Year12.58%
Revenue Next 2Y12.88%
Revenue Next 3Y12.99%
Revenue Next 5Y11.4%

3.3 Evolution

  • Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
BZ Yearly Revenue VS EstimatesBZ Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033 5B 10B 15B
BZ Yearly EPS VS EstimatesBZ Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033 2 4 6 8 10

More info and screens

Find the best growth stocksShow best growing peers

7

4. BZ Valuation Analysis

4.1 Price/Earnings Ratio

  • BZ is valuated correctly with a Price/Earnings ratio of 14.26.
  • Based on the Price/Earnings ratio, BZ is valued a bit cheaper than the industry average as 68.18% of the companies are valued more expensively.
  • The average S&P500 Price/Earnings ratio is at 26.74. BZ is valued slightly cheaper when compared to this.
  • With a Price/Forward Earnings ratio of 11.87, the valuation of BZ can be described as very reasonable.
  • BZ's Price/Forward Earnings ratio is a bit cheaper when compared to the industry. BZ is cheaper than 70.45% of the companies in the same industry.
  • When comparing the Price/Forward Earnings ratio of BZ to the average of the S&P500 Index (24.82), we can say BZ is valued rather cheaply.
Industry RankSector Rank
PE 14.26
Fwd PE 11.87
BZ Price Earnings VS Forward Price EarningsBZ Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, BZ is valued cheaply inside the industry as 86.36% of the companies are valued more expensively.
  • 75.00% of the companies in the same industry are more expensive than BZ, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 11.93
EV/EBITDA 6.48
BZ Per share dataBZ EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6

4.3 Compensation for Growth

  • The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • BZ has a very decent profitability rating, which may justify a higher PE ratio.
  • A more expensive valuation may be justified as BZ's earnings are expected to grow with 21.02% in the coming years.
PEG (NY)0.42
PEG (5Y)N/A
EPS Next 2Y23.01%
EPS Next 3Y21.02%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

2

5. BZ Dividend Analysis

5.1 Amount

  • BZ has a yearly dividend return of 0.91%, which is pretty low.
  • In the last 3 months the price of BZ has falen by -28.62%. A price decline artificially increases the dividend yield. It may be a sign investors do not expect the dividend to last.
  • Compared to an average industry Dividend Yield of 1.64, BZ pays a bit more dividend than its industry peers.
  • With a Dividend Yield of 0.91, BZ pays less dividend than the S&P500 average, which is at 1.82.
Industry RankSector Rank
Dividend Yield 0.91%

5.2 History

  • BZ has paid a dividend for less than 5 years, so there is no long track record yet.
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0
BZ Yearly Dividends per shareBZ Yearly Dividends per shareYearly Dividends per share 2023 2025 0.05 0.1 0.15

5.3 Sustainability

DPN/A
EPS Next 2Y23.01%
EPS Next 3Y21.02%
BZ Yearly Income VS Free CF VS DividendBZ Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2019 2020 2021 2022 2023 2024 0 1B -1B 2B

More info and screens

Find the best dividend stocksShow peers with best dividend

BZ Fundamentals: All Metrics, Ratios and Statistics

KANZHUN LTD - ADR

NASDAQ:BZ (3/5/2026, 8:00:02 PM)

After market: 15.5 -0.04 (-0.26%)

15.54

-0.33 (-2.08%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCommercial & Professional Services
GICS IndustryProfessional Services
Earnings (Last)11-18
Earnings (Next)03-09
Inst Owners81.59%
Inst Owner Change-0.65%
Ins Owners0.07%
Ins Owner ChangeN/A
Market Cap7.24B
Revenue(TTM)8.01B
Net Income(TTM)2.49B
Analysts84.29
Price Target26.7 (71.81%)
Short Float %7.41%
Short Ratio4.6
Dividend
Industry RankSector Rank
Dividend Yield 0.91%
Yearly Dividend0
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)5.8%
Min EPS beat(2)1.34%
Max EPS beat(2)10.26%
EPS beat(4)3
Avg EPS beat(4)4.5%
Min EPS beat(4)-0.61%
Max EPS beat(4)10.26%
EPS beat(8)7
Avg EPS beat(8)7.78%
EPS beat(12)11
Avg EPS beat(12)266%
EPS beat(16)14
Avg EPS beat(16)207.5%
Revenue beat(2)0
Avg Revenue beat(2)-2.35%
Min Revenue beat(2)-3.08%
Max Revenue beat(2)-1.62%
Revenue beat(4)0
Avg Revenue beat(4)-2.34%
Min Revenue beat(4)-3.08%
Max Revenue beat(4)-1.62%
Revenue beat(8)0
Avg Revenue beat(8)-1.86%
Revenue beat(12)3
Avg Revenue beat(12)-1.32%
Revenue beat(16)4
Avg Revenue beat(16)-1.07%
PT rev (1m)0%
PT rev (3m)2.86%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-0.39%
EPS NY rev (1m)0%
EPS NY rev (3m)1.87%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-0.47%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.12%
Valuation
Industry RankSector Rank
PE 14.26
Fwd PE 11.87
P/S 6.23
P/FCF 11.93
P/OCF 11.93
P/B 2.59
P/tB 2.6
EV/EBITDA 6.48
EPS(TTM)1.09
EY7.01%
EPS(NY)1.31
Fwd EY8.43%
FCF(TTM)1.3
FCFY8.38%
OCF(TTM)1.3
OCFY8.38%
SpS2.49
BVpS6
TBVpS5.97
PEG (NY)0.42
PEG (5Y)N/A
Graham Number12.13
Profitability
Industry RankSector Rank
ROA 10.31%
ROE 12.92%
ROCE 11.13%
ROIC 9.77%
ROICexc 1069.68%
ROICexgc 2915.11%
OM 26.94%
PM (TTM) 31.09%
GM 84.53%
FCFM 52.23%
ROA(3y)5.02%
ROA(5y)-3.62%
ROE(3y)6.59%
ROE(5y)-5.82%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.49%
GM growth 5Y-0.72%
F-Score7
Asset Turnover0.33
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA 0
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage 250
Cash Conversion 157.29%
Profit Quality 168.02%
Current Ratio 4.18
Quick Ratio 4.18
Altman-Z N/A
F-Score7
WACC7.54%
ROIC/WACC1.3
Cap/Depr(3y)260.87%
Cap/Depr(5y)288.66%
Cap/Sales(3y)11.74%
Cap/Sales(5y)9.69%
Profit Quality(3y)326.06%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)30.62%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%31.71%
EPS Next Y34.19%
EPS Next 2Y23.01%
EPS Next 3Y21.02%
EPS Next 5Y-2.51%
Revenue 1Y (TTM)12.66%
Revenue growth 3Y19.98%
Revenue growth 5Y49.09%
Sales Q2Q%13.17%
Revenue Next Year12.58%
Revenue Next 2Y12.88%
Revenue Next 3Y12.99%
Revenue Next 5Y11.4%
EBIT growth 1Y112.75%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year81.29%
EBIT Next 3Y33.38%
EBIT Next 5Y21.39%
FCF growth 1Y83.9%
FCF growth 3Y24.82%
FCF growth 5YN/A
OCF growth 1Y83.9%
OCF growth 3Y29.23%
OCF growth 5YN/A

KANZHUN LTD - ADR / BZ FAQ

What is the fundamental rating for BZ stock?

ChartMill assigns a fundamental rating of 6 / 10 to BZ.


Can you provide the valuation status for KANZHUN LTD - ADR?

ChartMill assigns a valuation rating of 7 / 10 to KANZHUN LTD - ADR (BZ). This can be considered as Undervalued.


What is the profitability of BZ stock?

KANZHUN LTD - ADR (BZ) has a profitability rating of 6 / 10.


What is the valuation of KANZHUN LTD - ADR based on its PE and PB ratios?

The Price/Earnings (PE) ratio for KANZHUN LTD - ADR (BZ) is 14.26 and the Price/Book (PB) ratio is 2.59.


How financially healthy is KANZHUN LTD - ADR?

The financial health rating of KANZHUN LTD - ADR (BZ) is 7 / 10.